MedTrace Logo

Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery

NCT05413980 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2024-05-09

No results posted yet for this study

Summary

This is a non-interventional, uncontrolled, prospective, multicenter, post marketing surveillance study.

Conditions

  • Post Operative Endophthalmitis

Interventions

OTHER

Moxifloxacin hydrochloride ophthalmic solution

Prospective observational study. There is no treatment allocation. Patients prescribed with 0.5% Moxifloxacin hydrochloride ophthalmic solution during the perioperative period of ophthalmic surgery are eligible to enroll into this study.

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-27
Primary Completion
2024-04-01
Completion
2024-04-01

Countries

  • India

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05413980 on ClinicalTrials.gov